Kardium
Kardium, headquartered in Burnaby, BC, Canada, developed the Globe Pulsed Field System, a catheter solution for treating atrial fibrillation, and holds over 100 related patents.
Services
Kardium specializes in developing advanced medical devices for the treatment of atrial fibrillation. Its primary offering, the Globe Pulsed Field System, provides a comprehensive solution that includes single-shot pulmonary vein isolation, high-definition mapping, and atrial ablation. This system is designed to enhance the accuracy and effectiveness of catheter ablation procedures.
Products
Kardium's flagship product is the Globe Pulsed Field System. This innovative device features a catheter with 122 electrodes, enabling single-shot pulmonary vein isolation and high-definition mapping. The system is engineered to facilitate atrial ablation and improve procedural outcomes for patients undergoing treatment for atrial fibrillation.
Sector
Kardium operates within the medical technology sector, focusing primarily on solutions for cardiac health. Its Globe Pulsed Field System is intended for use in the catheter ablation market, which is valued at approximately $6 billion. The company's technology aims to provide enhanced treatment options for atrial fibrillation, a common cardiac rhythm disorder.
History
Headquartered in Burnaby, BC, Canada, with a European office in Schwerte, Germany, Kardium has established itself as a leader in medical technology. The company has garnered recognition, being named Medical Technology Company of the Year in 2015 and 2021 by LifeSciences BC. Kardium's portfolio includes over 100 patents related to its Globe Pulsed Field Mapping and Ablation System, underscoring its commitment to innovation.